Association of HLA-G*01:01:02:01/G*01:04:01 polymorphism with gastric adenocarcinoma

Human Immunology

Volumn 77, Issue 2, 2016, Pages 153-157

  Khorrami, Samaneh ^a   Rahimi, Roghayeh ^b   Mohammadpour, Hemn ^b   Bahrami, Salahadin ^c   Yari, Fatemeh ^d   Poustchi, Hossein ^a   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^d HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Gastric adenocarcinoma; HLA G; Iranian population; Polymorphism

Indexed keywords

GENOMIC DNA; HLA G ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD LEVEL; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; IRANIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; IRAN; MIDDLE AGED; STOMACH TUMOR; TUMOR ESCAPE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-G ANTIGENS; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; TUMOR ESCAPE;

EID: 84958115892     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.11.005     Document Type: Article

References (40)

1. Malekzadeh R., Sotoudeh M., Derakhshan M.H., Mikaeli J., Yazdanbod A., Merat S., et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J. Clin. Pathol. 2004, 57:37.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71.
3. Nomura A.M., Wilkens L.R., Henderson B.E., Epplein M., Kolonel L.N. The association of cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes Control 2012, 23:51.
4. Duell E.J., Travier N., Lujan-Barroso L., Clavel-Chapelon F., Boutron-Ruault M.C., Morois S., et al. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am. J. Clin. Nutr. 2011, 94:1266.
5. Sivachandran N., Dawson C.W., Young L.S., Liu F.F., Middeldorp J., Frappier L. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J. Virol. 2012, 86:60.
6. Yang C.S. Vitamin nutrition and gastroesophageal cancer. J. Nutr. 2000, 130:338S.
7. Cao M., Yie S.M., Liu J., Ye S.R., Xia D., Gao E. Plasma soluble HLA-is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 2011, 78:120.
8. O'Callaghan C.A., Bell J.I. Structure and function of the human MHC class Ib molecules HLA-E, HLA-and HLA-G. Immunol. Rev. 1998, 163:129.
9. Chen H.X., Lin A., Shen C.J., Zhen R., Chen B.G., Zhang X., et al. Upregulation of human leukocyte antigen-expression and its clinical significance in ductal breast cancer. Hum. Immunol. 2010, 71:892.
10. Diepstra A., Poppema S., Boot M., Visser L., Nolte I.M., Niens M., et al. HLA-protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Tissue Antigens 2008, 71:219.
11. Heinrichs H., Orr H.T. HLA non-A, B, C class I genes: their structure and expression. Immunol. Res. 1990, 9:265.
12. Anthony, Nolan, Research, Institute: Full List of HLA Class I alleles Available at: <>. Accessed 2010, 15 April. http://hla.alleles.org/data/txt/g_nuc.txt.
13. Castelli E.C., Mendes C.T., Deghaide N.H.S., de Albuquerque R.S., Muniz Y.C.N., Simoes R.T., et al. The genetic structure of 3 ' untranslated region of the HLA-gene: polymorphisms and haplotypes. Genes Immunol. 2010, 11:134.
14. Larsen M.H., Hviid T.V.F. Human leukocyte antigen-polymorphism in relation to expression, function, and disease. Hum. Immunol. 2009, 70:1026.
15. Pandey M.K., Rani R., Agrawal S. An update in recurrent spontaneous abortion. Arch. Gynecol. Obstet. 2005, 272:95.
16. Hylenius S., Andersen A.M., Melbye M., Hviid T.V. Association between HLA-genotype and risk of pre-eclampsia: a case-control study using family triads. Mol. Hum. Reprod. 2004, 10:237.
17. Nicolae D., Cox N.J., Lester L.A., Schneider D., Tan Z., Billstrand C., et al. Fine mapping and positional candidate studies identify HLA-as an asthma susceptibility gene on chromosome 6p21. Am. J. Hum. Genet. 2005, 76:349.
18. Gazit E., Slomov Y., Goldberg I., Brenner S., Loewenthal R. HLA-is associated with pemphigus vulgaris in Jewish patients. Hum. Immunol. 2004, 65:39.
19. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble HLA-A,-B,-and -molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 2003, 33:125.
20. Fournel S., Huc X., Aguerre-Girr M., Solier C., Legros M., Praud-Brethenou C., et al. Comparative reactivity of different HLA-monoclonal antibodies to soluble HLA-molecules. Tissue Antigens 2000, 55:510.
21. He X., Dong D.D., Yie S.M., Yang H., Cao M., Ye S.R., et al. HLA-expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann. Surg. Oncol. 2010, 17:1459.
22. Association: JGC: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998, 1:10.
23. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature 2001, 411:380.
24. Hviid T.V., Milman N., Hylenius S., Jakobsen K., Jensen M.S., Larsen L.G. HLA-polymorphisms and HLA-expression in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2006, 23:30.
25. Hviid T.V., Hylenius S., Lindhard A., Christiansen O.B. Association between human leukocyte antigen-genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004, 64:66.
26. Castelli E.C., Mendes-Junior C.T., Viana de Camargo J.L., Donadi E.A. HLA-polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 2008, 72:149.
27. Simoes R.T., Goncalves M.A., Castelli E.C., Junior C.M., Bettini J.S., Discorde M.L., et al. HLA-polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod. Pathol. 2009, 22:1075.
28. Morandi F., Levreri I., Bocca P., Galleni B., Raffaghello L., Ferrone S., et al. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-release. Cancer Res. 2007, 67:6433.
29. Polakova K., Bandzuchova E., Kuba D., Russ G. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-expression in human leukemia cell lines. Leukemia Res. 2009, 33:518.
30. Rebmann V., van der Ven K., Passler M., Pfeiffer K., Krebs D., Grosse-Wilde H. Association of soluble HLA-plasma levels with HLA-alleles. Tissue Antigens 2001, 57:15.
31. Rahimi R., Hosseini A.Z., Yari F. The polymorphism of human leucocyte antigen-gene in a healthy population of Iran. Int. J. Immunogenet 2010, 37:269.
32. Singer G., Kurman R.J., McMaster M.T., Shih IeM HLA-immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am. J. Surg. Pathol. 2002, 26:914.
33. Lin A., Chen H.X., Zhu C.C., Zhang X., Xu H.H., Zhang J.G., et al. Aberrant human leucocyte antigen-expression and its clinical relevance in hepatocellular carcinoma. J. Cell Mol. Med. 2010, 14:2162.
34. Lin A., Zhang X., Xu H.H., Xu D.P., Ruan Y.Y., Yan W.H. HLA-expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer. Int. J. Cancer 2012, 131:150.
35. Bijen C.B., Bantema-Joppe E.J., de Jong R.A., Leffers N., Mourits M.J., Eggink H.F., et al. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int. J. Cancer 2010, 126:1417.
36. Nuckel H., Rebmann V., Durig J., Duhrsen U., Grosse-Wilde H. HLA-expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005, 105:1694.
37. Yie S.M., Yang H., Ye S.R., Li K., Dong D.D., Lin X.M. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann. Surg. Oncol. 2007, 14:2721.
38. Ye S.R., Yang H., Li K., Dong D.D., Lin X.M., Yie S.M. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod. Pathol. 2007, 20:375.
39. Ghandri N., Gabbouj S., Farhat K., Bouaouina N., Abdelaziz H., Nouri A., et al. Association of HLA-polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum. Immunol. 2011, 72:150.
40. Ishigami S., Natsugoe S., Miyazono F., Nakajo A., Tokuda K., Matsumoto M., et al. HLA-expression in gastric cancer. Anticancer Res. 2006, 26:2467.